Achieve Life Sciences announced that Richard Stewart, Achieve’s co-founder and current executive chairman, will reassume the role of CEO. John Bencich, who served as the company’s CEO for the past four years, will serve as an advisor during the transition. Additionally, the company announced that Thomas King, currently the lead independent director of the board, will assume the role of executive chairman.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ACHV:
- Achieve Life Sciences reports Q2 EPS (25c), consensus (23c)
- Achieve Life Sciences Reports Financial Results for Second Quarter 2024 and Provides Corporate Update
- Is ACHV a Buy, Before Earnings?
- Ladenburg bullish on Achieve Life Sciences following BTD for cytisinicline
- Achieve Life Sciences announcs FDA granted BTD for cytisinicline